Depression, sleep physiology, and antidepressant drugs

Depression and Anxiety

Volumn 14, Issue 1, 2001, Pages 19-28

  Winokur, Andrew ^a,d   Gary, Keith A ^a   Rodner, Shannon ^a   Rae Red, Carole ^b   Fernando, Antonio T ^c   Szuba, Martin P ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Hypersomnia; Insomnia; Polysomnography; REM; Sleep stages

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PLACEBO; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG MECHANISM; ELECTROENCEPHALOGRAM; HUMAN; INSOMNIA; LETHARGY; MAJOR CLINICAL STUDY; MENTAL DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEDATION; SLEEP DISORDER; SLEEP STAGE; SOMNOLENCE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; POLYSOMNOGRAPHY; SLEEP;

EID: 0034870913     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.1043     Document Type: Article

References (68)

1. Effects of fluoxetine on sleep architecture and quality of sleep in depressed patients
2. The effects of nefazodone on sleep architecture in depression
3. Fluoxetine and oculomotor activity during sleep in depressed patients
4. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients
5. Bupropion and nightmares
6. Fluoxetine versus trazodone: Efficacy and activating-sedating effects
7. Fluoxetine: Activating and sedating effects at multiple fixed doses
8. Perceptual changes with bupropion, a novel antidepressant
9. Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients
10. The pharmacologic profile of mirtazapine
11. Fluoxetine-induced sleep disturbance in depressed patients
12. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline
13. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial
14. The effects of fluoxetine on the polysomnogram of depressed outpatients: A pilot study
15. Sleep mechanisms and pathophysiology: Some clinical implications of the reciprocal interaction hypothesis of sleep cycle control
16. Human SWS is increased dose-dependently by seganserine and ritanserine
17. Effect of fluoxetine on sleep
18. Fluoxetine in major depression: Efficacy and safety and effects on sleep polysomnographic variables
19. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients
20. Tricyclic antidepressants and EEG sleep in depressed patients
21. REM sleep and central monoamine oxidase inhibition
22. Sleep and treatment prediction in endogenous depression
23. Fluvoxamine versus desipramine: Comparative polysomnographic effects
24. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression
25. Neuronal excitability modulation over the sleep cycle: A structural and mathematical model
26. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients
27. Effects of trazodone on the sleep of depressed subjects - A polygraphic study
28. Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive-behavioral therapy
29. REM sleep enhancement by bupropion in depressed men
30. Effects of paroxetine on human sleep
31. Sleep research in affective illness: State of the art circa 1987
32. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: Double-blind, placebo- and plasma-level-controlled evaluation
33. Synaptic effects of antidepressants
34. Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects
35. Effect of the antidepressant Org 3770 on human sleep
36. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
37. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities
38. Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers
39. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients
40. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder
41. Effect of pharmacologic treatments on the sleep of depressed patients
42. Slow wave sleep and 5-HT2 receptor sensitivity during maintenance tricyclic antidepressant treatment
43. Nefazodone - A novel antidepressant - May increase REM sleep
44. The effects of paroxetine and nefazodone on sleep: A placebo controlled trial
45. Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients
46. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression
47. EEG sleep measures in later-life bereavement depression. A randomized, double-blind, placebo-controlled evaluation of nortriptyline
48. Current status of EEG sleep in the assessment and treatment of depression
49. Effects of fluoxetine on the polysomnogram in outpatients with major depression
50. Effects of trazodone on EEG sleep and clinical state in major depression
51. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram
52. The effect of fluoxetine on sleep: A longitudinal, double-blind polysomnographic study of healthy volunteers
53. Cholinergic antagonists and REM sleep generation
54. Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep?
55. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs
56. Drug effects on REM sleep and on endogenous depression
57. Increased deep sleep after trazodone use: A double-blind placebo-controlled study in healthy young adults
58. Effects on sleep: A double-blind study comparing trimipramine to imipramine in depressed insomniac patients
59. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects
60. The effect of trimipramine on sleep in patients with major depressive disorder
61. The effects of antidepressants on sleep physiology
62. Sleep architecture and mood effects of sertraline in outpatients with major depression: A preliminary report
63. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: A pilot study
64. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients
65. Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects